Therapeutics News

The combined use of ablative fractional CO2 laser and poly-L-lactic acid to treat atrophic scars helped upregulate collagen synthesis to improve appearance of the scars, according to a study.

LEO Pharma and KLOX Technologies announced they have entered into a worldwide license and joint venture agreement to further the development and marketing of KLOX’s BioPhotonic dermatology technology platform. The CE-approved acne treatment uses a non-abrasive, non-thermal multi-LED light in conjunction with a photoactivable converter gel.

The American Academy of Dermatology has presented a list of everyday tips for preserving a more even skin tone in patients with melasma.

In vivo reflectance confocal microscopy allowed for accurate evaluation of imiquimod treatment in cases of lentigo maligna where surgery was contraindicated, researchers found.

Novartis has announced positive results from two phase III studies evaluating the interleukin-17A inhibitor, secukinumab, for the treatment of moderate-to-severe plaque psoriasis.

Ono Pharmaceuticals announced that its human anti-human PD-1 monoclonal antibody intravenous infusion 20 mg/100 mg, Opdivo, has been approved in Japan for manufacturing and marketing purposes for the treatment of unresectable melanoma.

In light of recent appropriate-use criteria, researchers have found Mohs micrographic surgery was an appropriate treatment in 72% of skin cancers.

Decreasing antibiotic treatment courses for adolescent acne from more than 6 months to 6 months resulted in an average savings of more than 29% per person, researchers found.

Auxilium Pharmaceuticals announced it has entered into a definitive agreement to merge with QLT to help drive shareholder value and increase research and development.

Although posaconazole therapy demonstrated antitrypanosomal activity in the treatment of Chagas’ disease, patients experienced more treatment failure during follow-up than when traditional benznidazole therapy was used.